Company intelligence / Profile preview

Louistar

Ownership: Private
Development stage: Other

Overview

LumiSTAR has developed proprietary live-cell bioimaging and iPSC technologies that enable more accurate preclinical drug screening. Their platforms allow personalized cell-based assays to better predict human responses—especially relevant for neurodegenerative diseases. The company has established partnerships with major device manufacturers and CDMOs to scale its offerings globally. No direct clinical trial results reported as they primarily provide enabling technologies rather than develop their own therapeutics at this time.

Therapeutic areas: NephrologyNeurologyOncology
Modalities: Induced pluripotent stem cell derived therapy (iPSC)Device (bioimaging technology)Small molecule (as part of drug screening applications)Cell therapy (enabling technology)
Industry: Non-Drug Biotech

Partnerships

Molecular Devices (California)PanasonicTaiwanese CDMO companiesStrategic partnerships with Japanese & American firms

Beyond the preview

Go deeper on Louistar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Louistar.

Explore the full profile